Telemedicine holds many promises but needs to be developed to be accepted by patients as an alternative to a visit to the doctor. Response to: 'Patient acceptance of using telemedicine for follow-up of lupus nephritis in the COVID-19 outbreak' by So et al.
Hendrik Schulze-KoopsChristof SpeckerKlaus KruegerPublished in: Annals of the rheumatic diseases (2020)